trending Market Intelligence /marketintelligence/en/news-insights/trending/btm4hpyWe11aNQpkEpBYqQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

AmerisourceBergen's Xcenda to acquire technology company Dymaxium

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


AmerisourceBergen's Xcenda to acquire technology company Dymaxium

AmerisourceBergen Corp.'s unit Xcenda LLC will acquire technology solutions company Dymaxium.

Dymaxium, through its online platform, FormularyDecisions.com, provides healthcare payers access to clinical evidence and economic product information that helps with assessing and evaluating products.

Dymaxium's platform has over 2,100 registered U.S. payers and healthcare decision-makers along with more than 2,300 products approved by the U.S. Food and Drug Administration.